CN108949647A - A kind of engineering bacteria and its application in production l-tyrosine - Google Patents
A kind of engineering bacteria and its application in production l-tyrosine Download PDFInfo
- Publication number
- CN108949647A CN108949647A CN201810352650.0A CN201810352650A CN108949647A CN 108949647 A CN108949647 A CN 108949647A CN 201810352650 A CN201810352650 A CN 201810352650A CN 108949647 A CN108949647 A CN 108949647A
- Authority
- CN
- China
- Prior art keywords
- gene
- tyrosine
- phenol
- escherichia coli
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/225—Tyrosine; 3,4-Dihydroxyphenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01027—L-Lactate dehydrogenase (1.1.1.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y106/00—Oxidoreductases acting on NADH or NADPH (1.6)
- C12Y106/99—Oxidoreductases acting on NADH or NADPH (1.6) with other acceptors (1.6.99)
- C12Y106/99003—NADH dehydrogenase (1.6.99.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/99—Other Carbon-Carbon Lyases (1.4.99)
- C12Y401/99002—Tyrosine phenol-lyase (4.1.99.2)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种工程菌及其在生产L-酪氨酸中的应用,属于生物工程技术领域。The invention relates to an engineering bacterium and its application in producing L-tyrosine, belonging to the technical field of bioengineering.
背景技术Background technique
L-酪氨酸(p-hydroxyphenylalanine)是人体的必须氨基酸,在医药和食品方面具有重要的应用。目前L-酪氨酸的来提取法、酶法、基因工程菌发酵法等。从毛法等原料水解提取L-酪氨酸过程污染大且纯度较低。大肠杆菌工程菌利用葡萄糖为原料重头合成L-酪氨酸的产率较低,目前无法与提取法及酶法竞争。L-tyrosine (p-hydroxyphenylalanine) is an essential amino acid for the human body and has important applications in medicine and food. At present, L-tyrosine is extracted, enzymatically, and fermented by genetically engineered bacteria. The process of hydrolyzing and extracting L-tyrosine from wool method and other raw materials has a lot of pollution and low purity. Escherichia coli engineering bacteria use glucose as a raw material to synthesize L-tyrosine with a low yield, which is currently unable to compete with extraction and enzymatic methods.
以酪氨酸酚裂解酶酶法生产L-酪氨酸是最为广泛应用的方法。已有多种方案被设计(Synthesis of L-Tyrosine or 3,4-Dihydroxyphenyl-L-alanine from DL-Serineand Phenol or Pyrocathechol,Agric.Biol.Chem.37(1973)493–499.中国专利201310168119.5),其中以丙酮酸和苯酚为底物的转化方法已在工业上实施。丙酮酸是较为昂贵的一种中间体,因此专利201310289373.0采用未提纯的丙酮酸料液直接进行转化,或者先用乳酸氧化酶氧化乳酸生成丙酮酸,然后再进一步催化生产L-酪氨酸(多酶偶联生物合成丙酮酸和L--酪氨酸研究,2014,南京大学硕士论文),但丙酮酸易分解,这种方案效率并不高。Enzymatic production of L-tyrosine with tyrosine phenol lyase is the most widely used method. A variety of schemes have been designed (Synthesis of L-Tyrosine or 3,4-Dihydroxyphenyl-L-alanine from DL-Serine and Phenol or Pyrocathechol, Agric. Biol. Chem. 37 (1973) 493-499. Chinese Patent 201310168119.5), Among them, the conversion method using pyruvate and phenol as substrates has been implemented industrially. Pyruvate is a relatively expensive intermediate, so patent 201310289373.0 uses unpurified pyruvic acid feed solution to directly convert, or first oxidize lactic acid with lactic acid oxidase to generate pyruvic acid, and then further catalyze the production of L-tyrosine (multiple Enzyme-coupled biosynthesis of pyruvate and L-tyrosine, 2014, Master Thesis of Nanjing University), but pyruvate is easy to decompose, and the efficiency of this scheme is not high.
发明内容Contents of the invention
基于目前各种方法的缺陷,本发明提出了不生成氧化氢的转化乳酸和苯酚产L-酪氨酸的生产方法,在改造大肠杆菌转运及辅酶合成体系的基础上,构建了三酶共表达的工程菌,实现了L-酪氨酸的高效生产。本发明所要解决的技术问题是提供一种能生产L-酪氨酸并减少杂质生成的重组菌,同时本发明要解决该菌株的构建和应用的技术问题。Based on the defects of various current methods, the present invention proposes a production method of converting lactic acid and phenol to produce L-tyrosine without generating hydrogen oxide, and constructs a co-expression of three enzymes on the basis of transforming E. coli transport and coenzyme synthesis system The engineered bacteria realized the high-efficiency production of L-tyrosine. The technical problem to be solved by the present invention is to provide a recombinant bacterium capable of producing L-tyrosine and reducing the generation of impurities, and at the same time, the present invention is to solve the technical problem of the construction and application of the strain.
本发明的第一个目的是提供能低成本生产纯多左旋巴的重组大肠杆菌;所述重组大肠杆菌同时表达了外源L-乳酸脱氢酶、NADH氧化酶和酪氨酸酚裂解酶,并在宿主大肠杆菌的基础上敲除了L-酪氨酸吸收基因。The first object of the present invention is to provide recombinant Escherichia coli capable of producing pure doloxetamine at low cost; said recombinant Escherichia coli expresses exogenous L-lactate dehydrogenase, NADH oxidase and tyrosine phenol lyase simultaneously, And the L-tyrosine uptake gene was knocked out on the basis of the host Escherichia coli.
在一种实施方式中,所述外源L-乳酸脱氢酶为乳酸菌来源的L-乳酸脱氢酶。外源的NADH氧化酶为乳酸菌来源的NADH氧化酶。In one embodiment, the exogenous L-lactate dehydrogenase is L-lactate dehydrogenase derived from lactic acid bacteria. The exogenous NADH oxidase is NADH oxidase derived from lactic acid bacteria.
在一种实施方式中,所述乳酸脱氢酶来自于Lactococcus lactis ATCC 19257、Lactobacillus plantarum ATCC 14917。In one embodiment, the lactate dehydrogenase is from Lactococcus lactis ATCC 19257, Lactobacillus plantarum ATCC 14917.
在一种实施方式中,所述乳酸脱氢酶的氨基酸序列是NCBI上accession NO为WP_003131075.1、KRL33571.1的序列。In one embodiment, the amino acid sequence of the lactate dehydrogenase is the sequence whose accession NO is WP_003131075.1 and KRL33571.1 on NCBI.
在一种实施方式中,所述乳酸脱氢酶的核苷酸序列是NCBI上accession NO为:NZ_JXJZ01000017REGION:18532..19509、AZEJ01000016REGION:16296..17249的序列。In one embodiment, the nucleotide sequence of the lactate dehydrogenase is the sequence whose accession NO on NCBI is: NZ_JXJZ01000017REGION:18532..19509, AZEJ01000016REGION:16296..17249.
在一种实施方式中,所述NADH氧化酶来自Lactococcus lactis ATCC 19257、Lactobacillus sanfranciscensis DSM20451、Lactobacillus brevis ATCC 14869。In one embodiment, the NADH oxidase is from Lactococcus lactis ATCC 19257, Lactobacillus sanfranciscensis DSM20451, Lactobacillus brevis ATCC 14869.
在一种实施方式中,所述NADH氧化酶的氨基酸序列是NCBI上accession NO为WP_032950924.1、WP_056958268.1、ERK43827.1序列。In one embodiment, the amino acid sequence of the NADH oxidase is the sequence of accession NO WP_032950924.1, WP_056958268.1 and ERK43827.1 on NCBI.
在一种实施方式中,所述NADH氧化酶的核苷酸序列是NCBI上accession NO为:NZ_JXJZ01000002REGION:complement(39571..40911)、NZ_AYYM01000013REGION:complement(15875..17233)、AWVK01000048REGION:complement(50022..51416)的序列。In one embodiment, the nucleotide sequence of the NADH oxidase is the accession NO on NCBI: NZ_JXJZ01000002REGION:complement(39571..40911), NZ_AYYM01000013REGION:complement(15875..17233), AWVK01000048REGION:complement(50022. .51416) sequence.
在一种实施方式中,所述L-乳酸脱氢酶、NADH氧化酶、酪氨酸酚裂解酶是通过pETDuet-1共表达的。In one embodiment, the L-lactate dehydrogenase, NADH oxidase, and tyrosine phenol lyase are co-expressed by pETDuet-1.
在一种实施方式中,所述酪氨酸酚裂解酶来源于草生欧文氏菌(Erwiniaherbicola)、中间柠檬酸菌(Citrobacter intermedius)、弗氏柠檬酸菌(Citrobacterfreundii)、嗜热菌Symbiobacterium thermophilum或者Symbiobacteriumtoebii。In one embodiment, the tyrosine phenol lyase is derived from Erwinia herbicola, Citrobacter intermedius, Citrobacter freundii, Symbiobacterium thermophilum or Symbiobacterium toebii .
在一种实施方式中,所述酪氨酸酚裂解酶来源于Citrobacter freundii ATCC8090,其氨基酸序列是NCBI上accession NO为WP_003837154.1的序列。In one embodiment, the tyrosine phenol lyase is derived from Citrobacter freundii ATCC8090, and its amino acid sequence is the sequence whose accession NO is WP_003837154.1 on NCBI.
在一种实施方式中,所述L-酪氨酸吸收基因包括L-酪氨酸分解基因、苯酚分解基因中的任意一种或者两种组合。In one embodiment, the L-tyrosine uptake gene includes any one or a combination of L-tyrosine decomposing gene and phenol decomposing gene.
在一种实施方式中,所述L-酪氨酸分解基因为hpaD、mhpB中的任意一种或者两种组合。In one embodiment, the L-tyrosine decomposition gene is any one or a combination of hpaD and mhpB.
在一种实施方式中,所述苯酚分解基因为hpaD、mhpB中的任意一种或者两种组合。In one embodiment, the phenol decomposing gene is any one or a combination of hpaD and mhpB.
在一种实施方式中,所述L-酪氨酸分解基因和苯酚分解基因的核苷酸序列是NCBI上,NCBI上accession NO为:NC_012892REGION:complement(4505585..4506436)和NC_012892 REGION:339806..340750。In one embodiment, the nucleotide sequences of the L-tyrosine decomposing gene and the phenol decomposing gene are on NCBI, and the accession NO on NCBI is: NC_012892REGION:complement (4505585..4506436) and NC_012892 REGION:339806. .340750.
在一种实施方式中,所述重组大肠杆菌还强化表达了将底物转运至细胞内的乳酸转运蛋白基因、苯酚转运相关基因、氨根离子转运基因中的任意一种或者多种。In one embodiment, the recombinant Escherichia coli further expresses any one or more of lactate transporter genes, phenol transport-related genes, and ammonium ion transport genes that transport substrates into cells.
在一种实施方式中,所述重组大肠杆菌还进一步强化表达了NAD合成基因、磷酸吡多醛合成相关基因中的任意一种或者多种。In one embodiment, the recombinant Escherichia coli further enhances the expression of any one or more of NAD synthesis genes and pyridoxal phosphate synthesis-related genes.
在一种实施方式中,所述强化表达的基因为lldP(乳酸转运基因)、amtB(氨根离子转运基因)、hpaX(苯酚转运基因)、mhpT(苯酚转运基因)、icsA(NAD合成基因)、nadA(NAD合成基因)、pdxJ(磷酸吡多醛合成基因)中的任意一种或多种。In one embodiment, the genes for enhanced expression are lldP (lactic acid transport gene), amtB (ammonium ion transport gene), hpaX (phenol transport gene), mhpT (phenol transport gene), icsA (NAD synthesis gene) Any one or more of , nadA (NAD synthesis gene), pdxJ (pyridoxal phosphate synthesis gene).
在一种实施方式中,所述宿主菌为Escherichia coli BL21(DE3)。In one embodiment, the host bacteria is Escherichia coli BL21(DE3).
在一种实施方式中,所述强化表达是通过将Escherichia coli BL21(DE3)基因组上所要强化表达的基因前增加组成型启动子。In one embodiment, the enhanced expression is achieved by adding a constitutive promoter in front of the gene to be expressed on the Escherichia coli BL21 (DE3) genome.
在一种实施方式中,所述lldP在NCBI上accession NO为:NC_012892REGION:3646638..3648293;amtB为NC_012892REGION:442006..443292;hpaX为;NC_012892REGION:complement(4502025..4503401);mhpT为NC_012892REGION:344788..345999;icsA为NC_012892REGION:complement(2526116..2527330);nadA为NC_012892REGION:740487..741530;pdxJ为NC_012892REGION:complement(2567591..2568322)。In one embodiment, the accession NO of the lldP on NCBI is: NC_012892REGION:3646638..3648293; amtB is NC_012892REGION:442006..443292; hpaX is; NC_012892REGION:complement(4502025..4503401); mtB is 92NC 344788..345999; icsA is NC_012892REGION:complement(2526116..2527330); nadA is NC_012892REGION:740487..741530; pdxJ is NC_012892REGION:complement(2567591..2568322).
本发明的第二个目的是提供一种生产光学纯L-酪氨酸的方法,所述方法是利用本发明的重组菌。The second object of the present invention is to provide a method for producing optically pure L-tyrosine by using the recombinant bacteria of the present invention.
在一种实施方式中,所述生产L-酪氨酸,是进行全细胞转化生产。In one embodiment, the production of L-tyrosine is carried out by transformation of whole cells.
在一种实施方式中,所述全细胞转化生产的体系中,细胞湿重1-200g/L,L-乳酸1-200g/L,苯酚浓度1-200g/L,pH 7.0-9.0,温度15-40℃,摇床转速250转/分钟;转化时间1-24小时。In one embodiment, in the system produced by whole cell transformation, the wet cell weight is 1-200g/L, the L-lactic acid is 1-200g/L, the phenol concentration is 1-200g/L, the pH is 7.0-9.0, and the temperature is 15 -40°C, shaker speed 250 rpm; transformation time 1-24 hours.
本发明的第三个目的是提供本发明重组菌或者本发明方法在化工、食品、医药等领域的应用。The third object of the present invention is to provide the application of the recombinant bacterium of the present invention or the method of the present invention in the fields of chemical industry, food, medicine and the like.
本发明的有益效果:Beneficial effects of the present invention:
本发明构建了一种新型的三酶共表达基因工程菌,该菌可应用于L-酪氨酸的生产。本发明选择方案不产过氧化氢,细胞不易分解L-酪氨酸,并且细胞内有较高的NAD含量。该生产过程简单且原料易得,具有良好的工业化应用前景。The invention constructs a novel three-enzyme co-expression genetically engineered bacterium, which can be applied to the production of L-tyrosine. The selection scheme of the present invention does not produce hydrogen peroxide, the cells are not easy to decompose L-tyrosine, and the cells have relatively high NAD content. The production process is simple and the raw materials are easy to obtain, and has good industrial application prospect.
具体实施方案specific implementation plan
本发明的大肠杆菌工程菌的功能核心是可以共表达三种酶,分别为L-乳酸脱氢酶(L-Lactate dehydrogenase)、NADH氧化酶(NADH oxidase)、酪氨酸酚裂解酶(tyrosinephenol-lyase)。其原理为:在工程菌全细胞内,L-乳酸脱氢酶以菌体内的NAD为辅酶将L-乳酸脱氢生成丙酮酸和NADH;NADH氧化酶将NADH氧化生成NAD,实现了辅酶NAD的再生。然后在酪氨酸酚裂解酶的作用下丙酮酸、氨根离子、苯酚合成为L-酪氨酸,同时敲除或强化表达大肠杆菌基因组上的相将关基因促进底物的转运及减少产物的分解。The functional core of the Escherichia coli engineering bacteria of the present invention can co-express three kinds of enzymes, which are respectively L-lactate dehydrogenase (L-Lactate dehydrogenase), NADH oxidase (NADH oxidase), tyrosinephenol lyase (tyrosinephenol- lyase). The principle is: in the whole cell of engineering bacteria, L-lactate dehydrogenase dehydrogenates L-lactate to pyruvate and NADH with NAD in the bacteria as a coenzyme; NADH oxidase oxidizes NADH to NAD, realizing the coenzyme NAD regeneration. Then, under the action of tyrosine phenol lyase, pyruvate, ammonium ion, and phenol are synthesized into L-tyrosine, and at the same time knockout or enhanced expression of related genes on the Escherichia coli genome promotes the transport of substrates and reduces products decomposition.
为解决上述技术问题,本发明采用的技术方案如下:In order to solve the problems of the technologies described above, the technical scheme adopted in the present invention is as follows:
1.本发明所涉及的菌株及质粒1. Bacterial strains and plasmids involved in the present invention
购自美国菌种保藏中心ATCC的Lactobacillus plantarum ATCC 14917、Lactococcus lactis ATCC 19257、Lactobacillus brevis ATCC 14869、Citrobacterfreundii ATCC 8090购自Novagen公司的pETDuet-1、pACYCDue-1、pCOLADuet-1、pRSFDuet-1质粒和Escherichia coli BL21(DE3)。Lactobacillus sanfranciscensis DSM20451购自德国微生物菌种保藏中心DSMZ。pCasRed、pCRISPR-gDNA购自镇江爱必梦生物科技有限公司。Lactobacillus plantarum ATCC 14917, Lactococcus lactis ATCC 19257, Lactobacillus brevis ATCC 14869, Citrobacterfreundii ATCC 8090 were purchased from American Culture Collection ATCC. coli BL21(DE3). Lactobacillus sanfranciscensis DSM20451 was purchased from DSMZ, the German Culture Collection of Microorganisms. pCasRed and pCRISPR-gDNA were purchased from Zhenjiang Aibimeng Biotechnology Co., Ltd.
2.大肠杆菌中相关基因的敲除及组成型强化表达2. Knockout and constitutive enhanced expression of related genes in Escherichia coli
(1)大肠杆菌芳香化合物降解基因的敲除(1) Knockout of Escherichia coli aroma compound degradation gene
本发明中的苯酚和L-酪氨酸都极易被大肠杆菌中的酶分解,根据文献(Biodegradation of Aromatic Compounds by Escherichia coli,Microbiol Mol BiolRev.2001,65(4):523–569.),将相关基因敲除,避免产物和底物的分解。选择的基因是hpaD和mhpB,NCBI上accession NO为:NC_012892REGION:complement(4505585..4506436)和NC_012892REGION:339806..340750。Both phenol and L-tyrosine in the present invention are easily decomposed by enzymes in Escherichia coli, according to the literature (Biodegradation of Aromatic Compounds by Escherichia coli, Microbiol Mol BiolRev.2001,65(4):523-569.), Knock out related genes to avoid decomposition of products and substrates. The selected genes are hpaD and mhpB, and the accession NO on NCBI is: NC_012892REGION:complement(4505585..4506436) and NC_012892REGION:339806..340750.
(2)大肠杆菌乳酸、苯酚、氨根离子转运基因的组成型强化表达(2) Constitutive enhanced expression of lactic acid, phenol, and ammonium ion transport genes in Escherichia coli
在全细胞转化过程中,需把底物转运至细胞内才能进行,增强乳酸转运蛋白有助于快速并长时间维持胞内底物的高浓度,有利于反应的进行。选择乳酸转运相关的基因是lldP,NCBI上accession NO为:NC_012892REGION:3646638..3648293。苯酚转运相关的基因是hpaX和mhpT,NCBI上accession NO为:NC_012892REGION:complement(4502025..4503401)和NC_012892REGION:344788..345999。氨根离子转运相关的基因是amtB,NCBI上accession NO为:NC_012892REGION:442006..443292。In the process of whole-cell transformation, the substrate needs to be transported into the cell. Enhancing the lactate transporter helps to maintain a high concentration of the intracellular substrate quickly and for a long time, which is conducive to the reaction. The gene related to lactate transport is lldP, and the accession NO on NCBI is: NC_012892REGION:3646638..3648293. The genes related to phenol transport are hpaX and mhpT, and the accession NO on NCBI is: NC_012892REGION:complement(4502025..4503401) and NC_012892REGION:344788..345999. The gene related to ammonium ion transport is amtB, and the accession NO on NCBI is: NC_012892REGION:442006..443292.
(3)大肠杆菌NAD合成相关基因的过表达(3) Overexpression of genes related to NAD synthesis in Escherichia coli
在乳酸脱氢过程中需要以NAD为辅酶,强化表达大肠杆菌NAD合成途径的关键酶,可以提高菌体内的NAD水平,从而有利于丙酮酸的生成。选择的基因有icsA、nadA。NCBI上accession NO为:NC_012892 REGION:complement(2526116..2527330)、NC_012892REGION:740487..741530。In the process of lactate dehydrogenation, NAD is needed as a coenzyme, and the key enzymes of the NAD synthesis pathway in E. coli can be enhanced to increase the level of NAD in the bacteria, thereby facilitating the generation of pyruvate. The selected genes are icsA and nadA. The accession NO on NCBI is: NC_012892 REGION:complement(2526116..2527330), NC_012892REGION:740487..741530.
(4)磷酸吡多醛(Pyridoxal phosphate)合成相关基因的表达(4) Expression of genes related to Pyridoxal phosphate synthesis
磷酸吡多醛(胺)是酪氨酸裂解酶的辅酶,过表达该辅酶途径中的核心基因pdxJ,有利于L-酪氨酸的合成。NCBI上accession NO为:NC_012892REGION:complement(2567591..2568322)。Pyridoxal (amine) phosphate is a coenzyme of tyrosine lyase, overexpressing the core gene pdxJ in the coenzyme pathway is beneficial to the synthesis of L-tyrosine. The accession NO on NCBI is: NC_012892REGION:complement(2567591..2568322).
3.乳酸转化生成丙酮酸相关酶的选择3. Selection of enzymes involved in conversion of lactic acid to pyruvate
(1)L-乳酸脱氢酶的选择(1) Selection of L-lactate dehydrogenase
L-乳酸是最为廉价的有机酸,目前主要以L-乳酸氧化酶氧化L-乳酸生产丙酮酸,在此过程中产生过氧化氢,过氧化氢会氧化丙酮酸生成乙酸。L-乳酸脱氢酶广泛存在多种微生物中,通常以NAD(NADP)为辅酶的乳酸脱氢酶更趋向于以丙酮酸为底物合成乳酸,但当乳酸过量或碳源只有乳酸时一些乳酸脱氢酶会脱掉乳酸的氢生成丙酮酸,以L-乳酸为底物将L-乳酸上生成的氢传递给辅酶NAD或NADP,从而生成NADH或NADPH。L-lactic acid is the cheapest organic acid. At present, L-lactic acid oxidase is mainly used to oxidize L-lactic acid to produce pyruvate. During this process, hydrogen peroxide is produced, and hydrogen peroxide will oxidize pyruvate to produce acetic acid. L-lactate dehydrogenase widely exists in a variety of microorganisms. Usually, lactate dehydrogenase with NAD (NADP) as a coenzyme tends to use pyruvate as a substrate to synthesize lactic acid. However, when lactic acid is excessive or the carbon source is only lactic acid, some lactic acid Dehydrogenase will remove the hydrogen of lactic acid to generate pyruvate, and use L-lactic acid as a substrate to transfer the hydrogen generated on L-lactic acid to the coenzyme NAD or NADP, thereby generating NADH or NADPH.
本发明从Lactococcus lactis ATCC 19257和Lactobacillus plantarum ATCC14917中分别得到L-乳酸脱氢酶基因llldh(氨基酸序列是WP_003131075.1)和lpldh(氨基酸序列是KRL33571.1),表达产物用于乳酸的脱氢。The present invention obtains L-lactate dehydrogenase genes llldh (amino acid sequence is WP_003131075.1) and lpldh (amino acid sequence is KRL33571.1) respectively from Lactococcus lactis ATCC 19257 and Lactobacillus plantarum ATCC14917, and the expression products are used for the dehydrogenation of lactic acid.
(2)NADH氧化酶的选择(2) Selection of NADH oxidase
乳酸脱氢酶从乳酸上脱氢生成丙酮酸NADH。NADH需要被NAD氧化酶氧化重新生成NAD,从而实现反应的持续进行。NADH氧化酶有产水型和产过氧化氢型两种,产水型的NADH氧化酶不会产生过氧化氢毒性。本发明分别从Lactobacillus sanfranciscensisDSM20451、Lactococcus lactis ATCC 19257、Lactobacillus brevis中得到产水型NADH氧化酶基因lsnox(氨基酸序列是WP_056958268.1)、llnox(氨基酸序列是WP_003131075.1)、lbnox(氨基酸序列是ERK43827),表达产物用于NAD的再生。.Lactate dehydrogenase dehydrogenates lactate to NADH pyruvate. NADH needs to be oxidized by NAD oxidase to regenerate NAD, so as to realize the continuous progress of the reaction. There are two types of NADH oxidase, the water-producing type and the hydrogen peroxide-producing type, and the water-producing NADH oxidase will not produce hydrogen peroxide toxicity. The present invention obtains water-producing NADH oxidase genes lsnox (amino acid sequence is WP_056958268.1), llnox (amino acid sequence is WP_003131075.1), lbnox (amino acid sequence is ERK43827) from Lactobacillus sanfranciscensis DSM20451, Lactococcus lactis ATCC 19257, and Lactobacillus brevis respectively , the expression product is used for the regeneration of NAD. .
(3)酪氨酸酚裂解酶的选择(3) Selection of tyrosine phenol lyase
来源于草生欧文氏菌(Erwinia herbicola)、中间柠檬酸菌(Citrobacterintermedius)、弗氏柠檬酸菌(Citrobacterfreundii)以及嗜热菌Symbiobacteriumthermophilum和Symbiobacterium toebii等的酪氨酸酚裂解酶是最常研究。本发明从中选择活性较高的来源于弗氏柠檬酸细菌的酶,从Citrobacter freundii ATCC 8090中得到酪氨酸酚裂解酶基因cftpl(氨基酸序列是WP_003837154.1)。Tyrosine phenol lyases from Erwinia herbicola, Citrobacter intermedius, Citrobacter freundii, and thermophiles Symbiobacterium thermophilum and Symbiobacterium toebii are the most commonly studied. The present invention selects the enzyme from Citrobacter freundii with higher activity, and obtains the tyrosine phenol lyase gene cftpl (amino acid sequence is WP_003837154.1) from Citrobacter freundii ATCC 8090.
4.共表达体系的构建及细胞的培养4. Construction of co-expression system and cell culture
目前大肠杆菌多基因共表达的有多种方法(大肠杆菌多基因共表达策略,中国生物工程杂志,2012,32(4):117-122),本发明采用刘向磊(合成生物学技术改造大肠杆菌生产莽草酸及白藜芦醇,2016,上海医药工业研究院,博士论文)所述方法构建,每个基因前均包含T7启动子和RBS结合点,理论上来讲因为每个基因前都有T7和RBS,因此基因的表达强度受排列次序的影响不大。每个质粒上包含三个基因,将构建好的质粒热转导入大肠杆菌感受态细胞中,并涂布于抗生素固体平板上,筛选得到阳性转化子,即得到重组大肠杆菌。细胞的培养:根据经典的重组大肠杆菌培养及诱导表达方案,将重组大肠杆菌按体积比为2%的量转接到LB发酵培养基(蛋白胨10g/L、酵母粉5g/L、NaCl 10g/L)中,当细胞OD600达到0.6-0.8后,加入终浓度为0.4mM的IPTG,在20℃诱导表达培养8h。诱导表达结束后,20℃、8000rpm、20分钟离心收集细胞。At present, there are multiple methods for the co-expression of Escherichia coli multigenes (Escherichia coli multigene co-expression strategy, China Biotechnology Journal, 2012, 32 (4): 117-122). Production of shikimic acid and resveratrol, 2016, Shanghai Pharmaceutical Industry Research Institute, Ph. and RBS, so the expression intensity of genes is not greatly affected by the arrangement order. Each plasmid contains three genes, and the constructed plasmid is thermally transfected into E. coli competent cells, and coated on an antibiotic solid plate, and positive transformants are screened to obtain recombinant E. coli. Cell culture: According to the classical recombinant Escherichia coli culture and induced expression scheme, the recombinant Escherichia coli was transferred to LB fermentation medium (peptone 10g/L, yeast powder 5g/L, NaCl 10g/L in volume ratio of 2%). In L), when the OD 600 of the cells reached 0.6-0.8, IPTG with a final concentration of 0.4 mM was added, and expression was induced at 20°C for 8 hours. After induction of expression, the cells were collected by centrifugation at 20° C., 8000 rpm, and 20 minutes.
5.全细胞转化生产L-酪氨酸5. Whole Cell Transformation to Produce L-Tyrosine
全细胞转化体系为:细胞湿重为1-200g/L,L-乳酸1-200g/L,苯酚1-200g/L,pH7.0-9.0,温度20-50℃,摇床转速250转/分钟;转化时间1-24小时。The whole cell transformation system is: cell wet weight 1-200g/L, L-lactic acid 1-200g/L, phenol 1-200g/L, pH7.0-9.0, temperature 20-50℃, shaker speed 250 rpm minutes; conversion time 1-24 hours.
6.样品的检测分析6. Detection and analysis of samples
L-酪氨酸的定量分析采用PerkinElmer Series 200高效液相色谱仪检测分析,配示差折光检测器。色谱条件为:流动相是甲醇-0.1%甲酸水(40:60)、采用汉邦Megres C18色谱柱(4.6×250mm,5μm),流速1ml/min、柱温30℃、进样量20μl。The quantitative analysis of L-tyrosine was detected and analyzed by PerkinElmer Series 200 high-performance liquid chromatography equipped with a differential refractive index detector. The chromatographic conditions are as follows: mobile phase is methanol-0.1% formic acid water (40:60), Hanbang Megres C18 column (4.6×250mm, 5μm), flow rate 1ml/min, column temperature 30℃, injection volume 20μl.
为了使本发明所要解决的技术问题、技术方案及有益效果更加清楚明白,以下结合实施例,对本发明进行详细的说明。应当说明的是,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。In order to make the technical problems, technical solutions and beneficial effects to be solved by the present invention clearer, the present invention will be described in detail below in conjunction with the embodiments. It should be noted that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
实施例1Example 1
根据文献Large scale validation of an efficient CRISPR/Cas-based multigene editing protocol in Escherichia coli.Microbial Cell Factories,2017,16(1):68所述的方法将Escherichia coli BL21(DE3)上的hpaD和mhpB进行单或双敲除,其中,本发明所用基因敲除的质粒为pCasRed与pCRISPR-gDNA(hpaD sgRNA)与同源臂(hpaDdonor)一起导入Escherichia coli BL21(DE3)上,Cas9/sgRNA诱发宿主在hpaD基因位点发生双链断裂,重组酶Red将hpaD donor整合到hpaD基因上,实现基因的敲除,并测序验证。hpaD sgRNA、hpaD donor、mhpB sgRNA、mhpB donor分别如序列表SEQ ID NO:11、SEQ IDNO:12、SEQ ID NO:13、SEQ ID NO:14所示。mhpB以同样的方式敲除。According to the method described in the literature Large scale validation of an efficient CRISPR/Cas-based multigene editing protocol in Escherichia coli. Microbial Cell Factories, 2017, 16(1): 68, hpaD and mhpB on Escherichia coli BL21 (DE3) were singled out Or double knockout, wherein, the gene knockout plasmid used in the present invention is pCasRed and pCRISPR-gDNA (hpaD sgRNA) and homologous arm (hpaDdonor) are introduced together on Escherichia coli BL21 (DE3), Cas9/sgRNA induces host in hpaD gene A double-strand break occurred at the site, and the recombinase Red integrated the hpaD donor into the hpaD gene to achieve gene knockout, which was verified by sequencing. hpaD sgRNA, hpaD donor, mhpB sgRNA, and mhpB donor are respectively shown in the sequence listing SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, and SEQ ID NO:14. mhpB was knocked out in the same way.
配置pH为8的溶液,苯酚或L-酪氨酸1g/L,湿菌体量100g/L,35℃放置10小时后测定浓度。表1中显示了反应体系中,苯酚或L-酪氨酸的剩余量。Prepare a solution with a pH of 8, 1 g/L of phenol or L-tyrosine, 100 g/L of wet bacteria, and measure the concentration after standing at 35°C for 10 hours. Table 1 shows the remaining amount of phenol or L-tyrosine in the reaction system.
表1不同菌株对底物和产物分解后的剩余浓度Table 1 Residual concentrations after substrate and product decomposition by different bacterial strains
很显然Escherichia coli BL21(ΔhpaDΔmhpB,DE3)效果最好,将之命名为Escherichia coli HM。Obviously, Escherichia coli BL21 (ΔhpaDΔmhpB, DE3) had the best effect, so it was named Escherichia coli HM.
实施例2Example 2
重组大肠杆菌构建:首先将编码乳酸脱氢酶、NADH氧化酶、酪氨酸酚酸裂解酶的基因,分别连接到质粒pETDuet-1上。得到各种三基因共表达重组质粒后,将质粒转化大肠杆菌Escherichia coli HM,利用氨苄青霉素平板筛选得到阳性转化子,即得到重组大肠杆菌。Recombinant Escherichia coli construction: First, the genes encoding lactate dehydrogenase, NADH oxidase, and tyrosine phenolic acid lyase were respectively connected to the plasmid pETDuet-1. After obtaining various three-gene co-expression recombinant plasmids, the plasmids were transformed into Escherichia coli HM, and positive transformants were obtained by screening with ampicillin plate, that is, recombinant Escherichia coli was obtained.
诱导表达方法:将重组大肠杆菌按体积比为2%的量转接到LB发酵培养基(蛋白胨10g/L、酵母粉5g/L、NaCl 10g/L)中,当细胞OD600达到0.6-0.8后,加入终浓度为0.4mM的IPTG,在20℃诱导表达培养8h。诱导表达结束后,20℃、8000rpm、20分钟离心收集细胞。Induced expression method: transfer recombinant Escherichia coli to LB fermentation medium (peptone 10g/L, yeast powder 5g/L, NaCl 10g/L) at a volume ratio of 2%, when the cell OD 600 reaches 0.6-0.8 Afterwards, IPTG with a final concentration of 0.4mM was added, and expression was induced at 20°C for 8h. After induction of expression, the cells were collected by centrifugation at 20° C., 8000 rpm, and 20 minutes.
收集到的细胞进行转化分析,结果如表2所示。转化体系中全细胞转化体系为:细胞湿重100g/L,L-乳酸50g/L,苯酚50g/L,pH 8.0,温度为35℃,摇床转速250转/分钟;转化时间10小时。The collected cells were analyzed for transformation, and the results are shown in Table 2. The whole cell transformation system in the transformation system is: cell wet weight 100g/L, L-lactic acid 50g/L, phenol 50g/L, pH 8.0, temperature 35°C, shaker speed 250 rpm; transformation time 10 hours.
表2共表达大肠杆菌生成L-酪氨酸的效率比较Table 2 co-expression Escherichia coli produces L-tyrosine efficiency comparison
由上表可以看出Escherichia coli HM/pETDuet-1-llnox-llldh-cftpl结果最好。It can be seen from the above table that Escherichia coli HM/pETDuet-1-llnox-llldh-cftpl has the best result.
实施例3Example 3
根据实例2所述的菌株构建方法(各类质粒根据说明明书采用不同的抗性平板筛选阳性转化子)及诱导表达方法,收集各类细胞进行转化分析,结果如表3所示。转化体系中全细胞转化体系为:细胞湿重50g/L,L-乳酸10g/L,苯酚10g/L,pH 7.0,温度为30℃,摇床转速250转/分钟;转化时间10小时。According to the strain construction method described in Example 2 (various types of plasmids were selected according to the instructions using different resistance plates to screen positive transformants) and induced expression method, various types of cells were collected for transformation analysis, and the results are shown in Table 3. The whole cell transformation system in the transformation system is: cell wet weight 50g/L, L-lactic acid 10g/L, phenol 10g/L, pH 7.0, temperature 30°C, shaker speed 250 rpm; transformation time 10 hours.
表3各种表达质粒对于生产L-酪氨酸的比较The various expression plasmids of table 3 are for the comparison of producing L-tyrosine
由上表可以看出采用pETDuet-1共表达时效果最好。It can be seen from the above table that the effect is the best when pETDuet-1 is used for co-expression.
实施例4Example 4
采用文献Large scale validation of an efficient CRISPR/Cas-based multigene editing protocol in Escherichia coli.Microbial Cell Factories,2017,16(1):68所述的方法,将Escherichia coli HM基因组上对应基因前增加大肠杆菌的3-磷酸甘油醛脱氢酶基因(gpdA)前的中等表达强度组成型启动子(PG),序列如SEQ ID NO:10所示。Using the method described in the literature Large scale validation of an efficient CRISPR/Cas-based multigene editing protocol in Escherichia coli.Microbial Cell Factories, 2017,16(1):68, the corresponding gene on the Escherichia coli HM genome was increased before the Escherichia coli The moderate expression strength constitutive promoter (PG) in front of the 3-phosphate glyceraldehyde dehydrogenase gene (gpdA), the sequence is shown in SEQ ID NO:10.
强化基因lldP表达时,以Escherichia coli HM基因组为模板,以引物lldP-FF/lldP-FR、lldP-gpdA-F/lldP-gpdA-R、lldP-RF/lldP-RR,扩增出上游、启动子、下游序列,并以lldP-FF和lldP-RR为引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含lldP sgRNA)一起转入Escherichia coli HM后,Cas9/sgRNA诱发宿主在lldP基因位点发生双链断裂,重组酶Red将gpdA启动子整合到lldP基因之前,并测序验证。When enhancing the expression of the gene lldP, the Escherichia coli HM genome was used as a template, and the primers lldP-FF/lldP-FR, lldP-gpdA-F/lldP-gpdA-R, lldP-RF/lldP-RR were used to amplify the upstream, promoter sub, downstream sequence, and lldP-FF and lldP-RR primers were fused into an expression cassette containing the gpdA promoter. Then, after the plasmid pCasRed and pCRISPR-gDNA (including lldP sgRNA) were transferred into Escherichia coli HM, Cas9/sgRNA induced the host to undergo a double-strand break at the lldP gene site, and the recombinase Red integrated the gpdA promoter into the front of the lldP gene, and Sequencing verification.
强化基因hpaX表达时,采用类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含hpaX sgRNA)一起转入Escherichia coli HM后,Cas9/sgRNA诱发宿主在hpaX基因位点发生双链断裂,重组酶Red将gpdA启动子整合到hpaX基因之前,并测序验证When enhancing the expression of the gene hpaX, a method similar to the method of enhancing the expression of the gene lldP was used to amplify the upstream, promoter, and downstream sequences first, and design primers to fuse to an expression cassette containing the gpdA promoter. Then, together with the plasmid pCasRed and pCRISPR-gDNA (including hpaX sgRNA) into Escherichia coli HM, Cas9/sgRNA induces a double-strand break in the host at the hpaX gene site, and the recombinase Red integrates the gpdA promoter into the front of the hpaX gene, and Sequencing verification
强化基因mhpT表达时,采用类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含mhpT sgRNA)一起转入Escherichia coli HM后,Cas9/sgRNA诱发宿主在mhpT基因位点发生双链断裂,重组酶Red将gpdA启动子整合到mhpT之前,并测序验证When enhancing the expression of the gene mhpT, a method similar to the method of enhancing the expression of the gene lldP is used to amplify the upstream, promoter, and downstream sequences first, and design primers to be fused to an expression cassette containing the gpdA promoter. Then, together with the plasmid pCasRed and pCRISPR-gDNA (including mhpT sgRNA) into Escherichia coli HM, Cas9/sgRNA induces a double-strand break in the host at the mhpT gene site, and the recombinase Red integrates the gpdA promoter into the front of mhpT, and then sequenced verify
强化基因amtB表达时,采用类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含amtB sgRNA)一起转入Escherichia coli HM后,Cas9/sgRNA诱发宿主在amtB基因位点发生双链断裂,重组酶Red将gpdA启动子整合到amtB基因之前,并测序验证When enhancing the expression of the gene amtB, a method similar to the method of enhancing the expression of the gene lldP is used to amplify the upstream, promoter, and downstream sequences first, and design primers to be fused to an expression cassette containing the gpdA promoter. Then, after the plasmid pCasRed and pCRISPR-gDNA (including amtB sgRNA) were transferred into Escherichia coli HM, Cas9/sgRNA induced a double-strand break at the amtB gene locus in the host, and the recombinase Red integrated the gpdA promoter into the front of the amtB gene, and Sequencing verification
下表为引物名称与序列表序号的对应索引。The following table is the corresponding index of the primer name and sequence number.
表4引物名称与序列表序号对照Table 4 Comparison of primer names and sequence numbers
根据实施例2所述的方法诱导表达,收集各类细胞进行转化分析,结果如表5所示。转化体系中全细胞转化体系为:细胞湿重10g/L,L-乳酸50g/L,苯酚10g/L,pH 8.0,温度为40℃,摇床转速250转/分钟;转化时间12小时。The expression was induced according to the method described in Example 2, and various types of cells were collected for transformation analysis. The results are shown in Table 5. The whole cell transformation system in the transformation system is: cell wet weight 10g/L, L-lactic acid 50g/L, phenol 10g/L, pH 8.0, temperature 40°C, shaker speed 250 rpm; transformation time 12 hours.
表5转化结果比较Table 5 Comparison of conversion results
将效果最好的Escherichia coli HM(PG-lldP,PG-hpaX,PG-mhpT)命名为Escherichia coli HMLHM。The best Escherichia coli HM (PG-lldP, PG-hpaX, PG-mhpT) was named Escherichia coli HMLHM.
实施例5Example 5
根据实例4的方法将Escherichia coli HMLHM中icsA和/或nadA基因前增加大肠杆菌的3-磷酸甘油醛脱氢酶基因(gpdA)前的中等表达强度组成型启动子(PG),序列如SEQID NO:22所示。然后再将质粒导入。According to the method for example 4, the medium expression strength constitutive promoter (PG) before the 3-phosphate glyceraldehyde dehydrogenase gene (gpdA) of Escherichia coli before the icsA and/or nadA gene in Escherichia coli HMLHM is increased, and the sequence is as SEQID NO :22. The plasmid is then reintroduced.
强化基因icsA表达时,采用实施例4中类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含icsA-gRNA)一起转入Escherichia coli HMLHM后,Cas9/sgRNA诱发宿主在icsA基因位点发生双链断裂,重组酶Red将gpdA启动子整合到icsA基因之前,并测序验证When enhancing the expression of the gene icsA, a method similar to that of enhancing the expression of the gene lldP in Example 4 was used to amplify the upstream, promoter, and downstream sequences first, and design primers to be fused to an expression cassette containing the gpdA promoter. Then, after the plasmid pCasRed and pCRISPR-gDNA (including icsA-gRNA) were transferred into Escherichia coli HMLHM, Cas9/sgRNA induced a double-strand break in the host at the icsA gene locus, and the recombinase Red integrated the gpdA promoter into the front of the icsA gene, And sequence verification
强化基因nadA表达时,采用实施例4中类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含nadA-gRNA)一起转入Escherichia coli HMLHM后,Cas9/sgRNA诱发宿主在icsA基因位点发生双链断裂,重组酶Red将gpdA启动子整合到nadA基因之前,并测序验证When enhancing the expression of the gene nadA, a method similar to that of enhancing the expression of the gene lldP in Example 4 was used to first amplify the upstream, promoter, and downstream sequences, and design primers to be fused to an expression cassette containing the gpdA promoter. Then, after the plasmid pCasRed and pCRISPR-gDNA (including nadA-gRNA) were transferred into Escherichia coli HMLHM, Cas9/sgRNA induced a double-strand break in the host at the icsA gene locus, and the recombinase Red integrated the gpdA promoter into the front of the nadA gene, And sequence verification
强化基因pdxJ表达时,采用实施例4中类似强化基因lldP表达的方法,先扩增出上游、启动子、下游序列,并设计引物融合为含有gpdA启动子的表达框。然后与质粒pCasRed、pCRISPR-gDNA(含pdxJ-gRNA)一起转入Escherichia coli HMLHM后,Cas9/sgRNA诱发宿主在icsA基因位点发生双链断裂,重组酶Red将gpdA启动子整合到pdxJ基因之前,并测序验证When enhancing the expression of the gene pdxJ, use the method similar to the method of enhancing the expression of the gene lldP in Example 4 to first amplify the upstream, promoter, and downstream sequences, and design primers to be fused to an expression cassette containing the gpdA promoter. Then, together with the plasmid pCasRed and pCRISPR-gDNA (including pdxJ-gRNA) into Escherichia coli HMLHM, Cas9/sgRNA induces a double-strand break in the host at the icsA gene site, and the recombinase Red integrates the gpdA promoter before the pdxJ gene, And sequence verification
下表为引物名称与序列表序号的对应索引。The following table is the corresponding index of the primer name and sequence number.
表6引物名称与序列表序号对照Table 6 Comparison of primer names and sequence numbers
基因改造完成后,将共表达质粒导入。根据实施例2所述的方法诱导表达,收集各类细胞进行转化分析,结果如表7所示。转化体系中全细胞转化体系为:细胞湿重为20g/L,L-乳酸200g/L,苯酚200g/L,pH 9.0,温度为30℃,摇床转速250转/分钟;转化时间24小时。After the genetic modification is completed, the co-expression plasmid is introduced. The expression was induced according to the method described in Example 2, and various types of cells were collected for transformation analysis. The results are shown in Table 7. The whole cell transformation system in the transformation system is: cell wet weight 20g/L, L-lactic acid 200g/L, phenol 200g/L, pH 9.0, temperature 30°C, shaker speed 250 rpm; transformation time 24 hours.
表7转化结果比较Table 7 Conversion results comparison
将最好的Escherichia coli HMLHM(PG-nadA,PG-pdxJ)命名为Escherichia coliHPName the best Escherichia coli HMLHM (PG-nadA, PG-pdxJ) as Escherichia coliHP
实施例6Example 6
根据实施例2所述诱导表达方法,将Escherichia coli HP/pETDuet-1-llnox-llldh-cftpl诱导表达完成后收集菌体,于100ml反应体系中,细胞湿重1g/L,L-乳酸1g/L,苯酚1g/L,pH 7.0,温度为15℃,摇床转速250转/分钟;转化时间1小时。测定结果,L-酪氨酸浓度为52mg/L。According to the induced expression method described in Example 2, after the induction and expression of Escherichia coli HP/pETDuet-1-llnox-llldh-cftpl was completed, the bacterial cells were collected, and in a 100ml reaction system, the cell wet weight was 1g/L, and the L-lactic acid was 1g/L. L, phenol 1g/L, pH 7.0, temperature 15°C, shaker speed 250 rpm; conversion time 1 hour. As a result of the measurement, the L-tyrosine concentration was 52 mg/L.
实施例7Example 7
根据实施例2所述诱导表达方法,将Escherichia coli HP/pETDuet-1-llnox-llldh-cftpl诱导表达完成后收集菌体,于100ml反应体系中,细胞湿重200g/L,L-乳酸200g/L,苯酚200g/L,pH 8.5,温度为40℃,摇床转速250转/分钟;转化时间24小时。测定结果,L-酪氨酸浓度为402g/L。L-酪氨酸难溶于水,高浓度下会析出,此结果为稀释后测定的结果。同样条件下Escherichia coli BL21(DE3)/pCOLADuet-1-llnox-llldh的L-酪氨酸浓度为365g/L。According to the induced expression method described in Example 2, after the induced expression of Escherichia coli HP/pETDuet-1-llnox-llldh-cftpl was completed, the bacterial cells were collected, and in a 100ml reaction system, the cell wet weight was 200g/L, and the L-lactic acid was 200g/L. L, phenol 200g/L, pH 8.5, temperature 40°C, shaker speed 250 rpm; conversion time 24 hours. As a result of the measurement, the concentration of L-tyrosine was 402 g/L. L-tyrosine is poorly soluble in water and will precipitate out at high concentrations. This result is the result of measurement after dilution. Under the same conditions, the L-tyrosine concentration of Escherichia coli BL21(DE3)/pCOLADuet-1-llnox-llldh was 365g/L.
以上所述的酶及其共表达基因工程菌的改造和构建、菌体的培养基组成及培养方法和全细胞生物转化仅为本发明的较佳实施例而已,并不用于限制本发明,理论上来讲其它的细菌、丝状真菌、放线菌、动物细胞均可进行基因组的改造,并用于多基因共表达的全细胞催化。凡在本发明的原则和精神之内所作的任何修改、等同替换。The above-mentioned transformation and construction of enzymes and their co-expression genetically engineered bacteria, the culture medium composition and culture method of the thalline and the whole cell biotransformation are only preferred embodiments of the present invention, and are not intended to limit the present invention. Generally speaking, other bacteria, filamentous fungi, actinomycetes, and animal cells can undergo genome modification and be used for whole-cell catalysis of multi-gene co-expression. Any modification and equivalent replacement made within the principle and spirit of the present invention.
序列表sequence listing
<110> 江南大学<110> Jiangnan University
<120> 一种工程菌及其在生产L-酪氨酸中的应用<120> An engineering bacterium and its application in the production of L-tyrosine
<130> 2018.3.15<130> 2018.3.15
<160> 18<160> 18
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 1<400> 1
gattgccacc gtccacgagg 20gattgccacc gtccacgagg 20
<210> 2<210> 2
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 2<400> 2
cggctggcag gctgaagaag 20cggctggcag gctgaagaag 20
<210> 3<210> 3
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 3<400> 3
ttaacggcgt cggcttcggg 20ttaacggcgt cggcttcggg 20
<210> 4<210> 4
<211> 25<211> 25
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 4<400> 4
aaatacaatc tctgtaggtt cttct 25aaatacaatc tctgtaggtt cttct 25
<210> 5<210> 5
<211> 50<211> 50
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 5<400> 5
tcggccactc atcaacatga ttcatgagtc tgttgctcat ctccttgtca 50tcggccactc atcaacatga ttcatgagtc tgttgctcat ctccttgtca 50
<210> 6<210> 6
<211> 50<211> 50
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 6<400> 6
tgacaaggag atgagcaaca gactcatgaa tcatgttgat gagtggccga 50tgacaaggag atgagcaaca gactcatgaa tcatgttgat gagtggccga 50
<210> 7<210> 7
<211> 50<211> 50
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 7<400> 7
cgtagttttg ttgccagaga ttcatggttt tctcctgtca ggaacgttcg 50cgtagttttg ttgccagaga ttcatggttt tctcctgtca ggaacgttcg 50
<210> 8<210> 8
<211> 50<211> 50
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 8<400> 8
cgaacgttcc tgacaggaga aaaccatgaa tctctggcaa caaaactacg 50cgaacgttcc tgacaggaga aaaccatgaa tctctggcaa caaaactacg 50
<210> 9<210> 9
<211> 25<211> 25
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 9<400> 9
taacacctga cccgcagtgt aaccg 25taacacctga cccgcagtgt aaccg 25
<210> 10<210> 10
<211> 1100<211> 1100
<212> DNA<212>DNA
<213> Escherichia coli BL21(DE3)<213>Escherichia coli BL21(DE3)
<400> 10<400> 10
atgaatcatg ttgatgagtg gccgatcgct acgtgggaag aaaccacgaa actccattgc 60atgaatcatg ttgatgagtg gccgatcgct acgtgggaag aaaccacgaa actccattgc 60
gcaatacgct gcgataacca gtaaaaagac cagccagtga atgctgattt gtaaccttga 120gcaatacgct gcgataacca gtaaaaagac cagccagtga atgctgattt gtaaccttga 120
atatttattt tccataacat ttcctgcttt aacataattt tccgttaaca taacgggctt 180atatttattt tccataacat ttcctgcttt aacataattt tccgttaaca taacggggctt 180
ttctcaaaat ttcattaaat attgttcacc cgttttcagg taatgactcc aacttattga 240ttctcaaaat ttcattaaat attgttcacc cgttttcagg taatgactcc aacttattga 240
tagtgtttta tgttcagata atgcccgatg actttgtcat gcagctccac cgattttgag 300tagtgtttta tgttcagata atgcccgatg actttgtcat gcagctccac cgattttgag 300
aacgacagcg acttccgtcc cagccgtgcc aggtgctgcc tcagattcag gttatgccgc 360aacgacagcg acttccgtcc cagccgtgcc aggtgctgcc tcagattcag gttatgccgc 360
tcaattcgct gcgtatatcg cttgctgatt acgtgcagct ttcccttcag gcgggattca 420tcaattcgct gcgtatatcg cttgctgatt acgtgcagct ttcccttcag gcgggattca 420
tacagcggcc agccatccgt catccatatc accacgtcaa agggtgacag caggctcata 480tacagcggcc agccatccgt catccatatc accacgtcaa agggtgacag caggctcata 480
agacgcccca gcgtcgccat agtgcgttca ccgaatacgt gcgcaacaac cgtcttccgg 540agacgcccca gcgtcgccat agtgcgttca ccgaatacgt gcgcaacaac cgtcttccgg 540
agcctgtcat acgcgtaaaa cagccagcgc tggcgcgatt tagccccgac atagccccac 600agcctgtcat acgcgtaaaa cagccagcgc tggcgcgatt tagccccgac atagccccac 600
tgttcgtcca tttccgcgca gacgatgacg tcactgcccg gctgtatgcg cgaggttacc 660tgttcgtcca tttccgcgca gacgatgacg tcactgcccg gctgtatgcg cgaggttacc 660
gactgcggcc tgagtttttt aagtgacgta aaatcgtgtt gaggccaacg cccataatgc 720gactgcggcc tgagtttttt aagtgacgta aaatcgtgtt gaggccaacg cccataatgc 720
gggcagttgc ccggcatcca acgccattca tggccatatc aatgattttc tggtgcgtac 780gggcagttgc ccggcatcca acgccattca tggccatatc aatgattttc tggtgcgtac 780
cgggttgaga agcggtgtaa gtgaactgca gttgccatgt tttacggcag tgagagcaga 840cgggttgaga agcggtgtaa gtgaactgca gttgccatgt tttacggcag tgagagcaga 840
gatagcgctg atgtccggcg gtgcttttgc cgttacgcac caccccgtca gtagctgaac 900gatagcgctg atgtccggcg gtgcttttgc cgttacgcac caccccgtca gtagctgaac 900
aggagggaca gctgatagaa acagaagcca ctggagcacc tcaaaaacac catcatacac 960aggagggaca gctgatagaa acagaagcca ctggagcacc tcaaaaacac catcatacac 960
taaatcagta agttggcagc atcaccccgt tttcagtacg ttacgtttca ctgtgagaat 1020taaatcagta agttggcagc atcaccccgt tttcagtacg ttacgtttca ctgtgagaat 1020
ggagattgcc catcccgcca tcctggtcta agcctggaaa ggatcaattt tcatccgaac 1080ggagattgcc catcccgcca tcctggtcta agcctggaaa ggatcaattt tcatccgaac 1080
gttcctgaca ggagaaaacc 1100gttcctgaca ggagaaaacc 1100
<210> 11<210> 11
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 11<400> 11
tatgcccgtc gatcgcgccc 20tatgcccgtc gatcgcgccc 20
<210> 12<210> 12
<211> 120<211> 120
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 12<400> 12
ccaagatcac gcacgtaccg tcgatgtatc tctctgaact gccagggaaa aaccacggtt 60ccaagatcac gcacgtaccg tcgatgtatc tctctgaact gccagggaaa aaccacggtt 60
agatcagcaa gcgttgccgg gaaatgggcg tcgataccat tatcgttttc gacacccact 120agatcagcaa gcgttgccgg gaaatgggcg tcgataccat tatcgttttc gacacccact 120
<210> 13<210> 13
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 13<400> 13
tcatcgagta cctcttgcgc 20tcatcgagta cctcttgcgc 20
<210> 14<210> 14
<211> 120<211> 120
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 14<400> 14
tagcctgata tgcacgctta tcttcactgt ctttcccact cgccgctggt gggatatgtc 60tagcctgata tgcacgctta tcttcactgt ctttcccact cgccgctggt gggatatgtc 60
aatggcgtga ttgccagcgc ccgcgagcgt attgcggctt tctcccctga actggtggtg 120aatggcgtga ttgccagcgc ccgcgagcgt attgcggctt tctcccctga actggtggtg 120
<210> 15<210> 15
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 15<400> 15
cgaacagaaa gacgatcagg 20cgaacagaaa gacgatcagg 20
<210> 16<210> 16
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 16<400> 16
cgtcgcggtc agtaatgtga 20cgtcgcggtc agtaatgtga 20
<210> 17<210> 17
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 17<400> 17
ggtaatggct gcacctgcgg 20ggtaatggct gcacctgcgg 20
<210> 18<210> 18
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列<213> Artificial sequence
<400> 18<400> 18
gcgggatgaa gatgatgaag 20gcgggatgaa gatgatgaag 20
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810352650.0A CN108949647B (en) | 2018-04-19 | 2018-04-19 | A kind of engineering bacteria and its application in producing L-tyrosine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810352650.0A CN108949647B (en) | 2018-04-19 | 2018-04-19 | A kind of engineering bacteria and its application in producing L-tyrosine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108949647A true CN108949647A (en) | 2018-12-07 |
| CN108949647B CN108949647B (en) | 2020-12-29 |
Family
ID=64498652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810352650.0A Active CN108949647B (en) | 2018-04-19 | 2018-04-19 | A kind of engineering bacteria and its application in producing L-tyrosine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108949647B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115011537A (en) * | 2022-06-14 | 2022-09-06 | 湖北工业大学 | An engineering bacterium capable of producing high optical purity L-lactic acid induced by dual anaerobic promoters and its preparation method and application |
| CN115786416A (en) * | 2022-12-23 | 2023-03-14 | 杭州唯铂莱生物科技有限公司 | Preparation method and fermentation product of L-tyrosine |
| CN116064260A (en) * | 2022-07-07 | 2023-05-05 | 福建科宏生物工程股份有限公司 | Recombinant bacterium for preparing L-tyrosine and preparation method thereof |
| KR20230123544A (en) * | 2022-02-16 | 2023-08-24 | 대상 주식회사 | Novel variant of transporter and method for preparing L-aromatic amino acid using the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103224972A (en) * | 2013-05-09 | 2013-07-31 | 湖北新生源生物工程股份有限公司 | L-tyrosine preparation method through enzymatic conversion |
| CN103343149A (en) * | 2013-07-10 | 2013-10-09 | 南京大学 | Preparation method of L-tyrosine or L-tyrosine derivative employing enzyme conversion |
| CN104498555A (en) * | 2014-12-08 | 2015-04-08 | 宁波市镇海海德生化科技有限公司 | Supplementation and enzymatic conversion based ultrasonic-assisted preparation method of L-tyrosine |
-
2018
- 2018-04-19 CN CN201810352650.0A patent/CN108949647B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103224972A (en) * | 2013-05-09 | 2013-07-31 | 湖北新生源生物工程股份有限公司 | L-tyrosine preparation method through enzymatic conversion |
| CN103343149A (en) * | 2013-07-10 | 2013-10-09 | 南京大学 | Preparation method of L-tyrosine or L-tyrosine derivative employing enzyme conversion |
| CN104498555A (en) * | 2014-12-08 | 2015-04-08 | 宁波市镇海海德生化科技有限公司 | Supplementation and enzymatic conversion based ultrasonic-assisted preparation method of L-tyrosine |
Non-Patent Citations (3)
| Title |
|---|
| VISHVANATH TIWARI: "In vitro Engineering of Novel Bioactivity in the Natural Enzymes", 《FRONTIERS IN CHEMISTRY》 * |
| 常俊俊 等: "重组酪氨酸酚裂解酶全细胞催化合成L-酪氨酸", 《精细化工》 * |
| 高晗: "多酶偶联生物合成丙酮酸和L-酪氨酸研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230123544A (en) * | 2022-02-16 | 2023-08-24 | 대상 주식회사 | Novel variant of transporter and method for preparing L-aromatic amino acid using the same |
| WO2023158175A1 (en) * | 2022-02-16 | 2023-08-24 | 대상 주식회사 | Novel transport protein variant and method for producing l-aromatic amino acid using same |
| KR102771793B1 (en) * | 2022-02-16 | 2025-02-25 | 대상 주식회사 | Novel variant of transporter and method for preparing L-aromatic amino acid using the same |
| CN115011537A (en) * | 2022-06-14 | 2022-09-06 | 湖北工业大学 | An engineering bacterium capable of producing high optical purity L-lactic acid induced by dual anaerobic promoters and its preparation method and application |
| CN115011537B (en) * | 2022-06-14 | 2023-06-23 | 湖北工业大学 | Engineering bacterium for producing high optical purity L-lactic acid by double anaerobic promoters and preparation method and application thereof |
| CN116064260A (en) * | 2022-07-07 | 2023-05-05 | 福建科宏生物工程股份有限公司 | Recombinant bacterium for preparing L-tyrosine and preparation method thereof |
| CN115786416A (en) * | 2022-12-23 | 2023-03-14 | 杭州唯铂莱生物科技有限公司 | Preparation method and fermentation product of L-tyrosine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108949647B (en) | 2020-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4886775B2 (en) | Production method of glycolic acid by coenzyme regeneration | |
| EP2710117B1 (en) | Recombinant microorganisms and methods of use thereof | |
| JP2019195330A (en) | Production of muconic acid from genetically engineered microorganisms | |
| JP4954985B2 (en) | Production method of glycolic acid by enhancing coenzyme synthesis | |
| CN109295113A (en) | A kind of method for producing hydroxytyrosol | |
| CN108949647A (en) | A kind of engineering bacteria and its application in production l-tyrosine | |
| CN108949652B (en) | Engineering bacterium and application thereof in producing caffeic acid | |
| CN109370967A (en) | A kind of engineering bacteria and its application in tyrosol production | |
| CN108949649A (en) | A kind of engineering bacteria and its application in production levodopa | |
| KR101163542B1 (en) | Methods of preparing for Biotransformed Vanillin from Isoeugenol | |
| JP7067706B2 (en) | Transformed microorganisms and their utilization | |
| US10870870B2 (en) | Engineering strain and application thereof in production of Danshensu | |
| CN108949657B (en) | An engineering bacterium and its application in co-production of danshensu and α-ketoglutarate | |
| CN108949650B (en) | A kind of production method of danshensu and engineering bacteria | |
| CN108949648B (en) | An engineering bacterium and its application to produce danshensu with cheap substrate | |
| US10829790B2 (en) | Recombinant E. coli and method of producing Danshensu by using same | |
| CN108949655B (en) | A kind of engineering bacteria and its application in the joint production of danshensu and pyruvate | |
| CN108949654B (en) | A kind of engineering bacteria and its application in producing α-ketoglutaric acid | |
| CN108949656B (en) | Engineering bacterium and application thereof in production of pyruvic acid | |
| CN108949840B (en) | A kind of engineering bacteria and its application in producing p-hydroxycinnamic acid | |
| CN108949651B (en) | A kind of engineering bacteria and its application to produce p-hydroxyphenyl lactic acid with cheap substrate | |
| JP2005278414A (en) | Methods for producing 1,3-propanediol and 3-hydroxypropionic acid | |
| CN108949653A (en) | A kind of engineering bacteria and its application in danshensu production | |
| CN108865960B (en) | An engineering bacterium and its application in the co-production of danshensu and alanine | |
| CN110305823B (en) | Method and strain for producing L-alanine by adopting lactic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230220 Address after: Floor 20, Unit 2, Building 1, Jinlan West Jingyuan, No. 56, Shinan Road, Science Avenue, High-tech Industrial Development Zone, Zhengzhou City, Henan Province, 450000 Patentee after: Zhuohong Chaoyuan Biotechnology (Zhengzhou) Co.,Ltd. Address before: No. 1800 Lihu Avenue, Wuxi City, Jiangsu Province Patentee before: Jiangnan University |